INT MEDICAL (01501) received notification from the China Securities Regulatory Commission regarding the application for the full circulation of H shares.

18:47 11/05/2026

Yingtai Medical (01501) announced that the company has submitted an application to the China Securities Regulatory Commission for the conversion of a total of 71,786,608 shares owned by 12 shareholders into H shares. The board of directors announced that on May 9, 2026, the company received a notice of approval for the full circulation of H shares issued by the China Securities Regulatory Commission on April 27, 2026, and Shanghai Yingtai Medical Equipment Co., Ltd., an onshore unlisted shares full circulation record notification.

ANNOUNCEMENT OF INT MEDICAL (01501): The company has announced that it has applied to the China Securities Regulatory Commission on behalf of 12 shareholders holding a total of 71,786,608 shares of domestic shares to convert them into H shares. The board of directors announced that on May 9, 2026, the company received a notice of record for the full circulation of H shares of Shanghai INT MEDICAL Equipment Co., Ltd. issued by the China Securities Regulatory Commission on April 27, 2026, for domestic unlisted shares.

JST GROUP (06687) spent 1.9975 million Hong Kong dollars to repurchase 12.88 thousand shares on May 11th.

Shenzhen Sunxing Light Alloys Materials (603978.SH): "Construction and completion of the third phase of the project to produce 15,000 tons of lithium hexafluorophosphate per year."

China Galaxy (06881) successfully issued 6 billion yuan corporate bonds.

JST GROUP (06687) spent 1.9975 million Hong Kong dollars to repurchase 12.88 thousand shares on May 11th.

Shenzhen Sunxing Light Alloys Materials (603978.SH): "Construction and completion of the third phase of the project to produce 15,000 tons of lithium hexafluorophosphate per year."

China Galaxy (06881) successfully issued 6 billion yuan corporate bonds.